Hide Board Information

Show Board Information

Endonovo Therapeutics, Inc. ENDV

Board Mod: CyberC

Asst Mods: learningthetruth CyberS Shilling financedirector

Last Post: 12/15/2022 10:00:44 AM

Board Marks: 22

Posts Today: 0

Board Views Today: 136

Endonovo Therapeutics, Inc. (OTCMRKTS: ENDV) Stock Message Board

1. ENDV Company Profile

    

2. ENDV Time & Sales

    

3. ENDV Recent News

    

4. ENDV Filings

    

5. ENDV Financials

    

6. ENDV Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

311	https://ci5.googleusercontent.com/proxy/30efGphce	CyberC	02/28/2019 1:12:05 AM
310	Endonovo Therapeutics Files Lawsuit against KVP	CyberC	02/24/2019 10:26:46 PM
309	Jan. 11, 2019 Press Releases Endonovo	CyberC	01/11/2019 12:39:14 PM
308	Great news! Sounds like a logical step to getting	gypsy7thof7	01/03/2019 5:38:37 PM
307	Press Releases Endonovo Therapeutics Enters into	CyberC	01/03/2019 11:35:17 AM
306	As of 12-31-2018, Scott Mann (President of ENDV)	CyberC	01/01/2019 2:52:51 PM
305	As of 12-20-2018, Scott Mann (President of ENDV)	CyberC	12/26/2018 10:36:02 AM
304	Press Releases Endonovo Therapeutics Announces	CyberC	12/18/2018 9:26:43 AM
303	Scott Mann's current stock count ... Common Stock	CyberC	12/13/2018 10:24:54 AM
302	Endonovo Expands SofPulse Commercialization 9:20	CyberC	12/13/2018 10:23:29 AM
301	Great news! Another product to market! This	gypsy7thof7	11/09/2018 1:05:10 AM
300	Press Releases Endonovo Therapeutics Announces	CyberC	11/08/2018 10:59:19 AM
299	Do we know when the financials come	gypsy7thof7	11/07/2018 5:37:41 PM
298	Endonovo Therapeutics Provides Update on Liver	CyberC	10/30/2018 11:07:51 PM
297	Another stock with nothing but good news lately.	gypsy7thof7	10/24/2018 4:36:16 PM
296	Press Releases Endonovo Therapeutics Provides	CyberC	10/22/2018 1:32:49 PM
295	Messed that last post up....mixed 2 stock	gypsy7thof7	10/17/2018 9:56:26 PM
294	Novice investor here but this really looks like a	gypsy7thof7	10/03/2018 11:12:59 PM
293	$ENDV at resistance$0.064 OTC (1)	PoemStone	10/02/2018 4:24:28 PM
292	38% 12.2M C.064 test .054+.06 Float 366,118,770	znewcar1	10/02/2018 4:08:37 PM
291	I wonder how this is going? Endonovo Therapeutics	CyberC	09/22/2018 12:04:05 PM
290	Scott's new Stock Total: Common Stock 09/17/2018	CyberC	09/22/2018 12:01:15 PM
289	Scott Mann stock count as of: Common Stock	CyberC	09/07/2018 7:22:02 PM
288	1. Name and Address of Reporting Person* Mann	CyberC	09/01/2018 2:07:21 AM
287	14% 10.2M C.0544 EOD rush (1)	znewcar1	08/31/2018 4:08:31 PM
286	52% 9.6M C.038 some early morning vol that found	znewcar1	08/27/2018 4:28:08 PM
285	Good catch. Thanks. As soon as that distribution	Shilling	08/22/2018 8:29:33 AM
284	Mann, Michael Scott President of ENDV 25,407,498	CyberC	08/14/2018 1:26:07 PM
283	Press Releases Endonovo Therapeutics Signs	CyberC	08/14/2018 10:45:25 AM
282	Endonovo Therapeutics, Inc. Endonovo	CyberC	08/14/2018 10:02:38 AM
281	What is the latest and greatest with this stock?	gypsy7thof7	08/10/2018 8:22:52 PM
280	$ENDV added to Bottom calling	PoemStone	06/14/2018 10:38:13 AM
279	MANN's Common Stock as of 06/04/2018: 25,143,289	CyberC	06/08/2018 10:17:16 PM
278	Ok we need some excitement around here. Has	Shilling	06/07/2018 1:09:57 AM
277	.22% 2.2M C.0550 a couple of interday BO	znewcar1	05/18/2018 4:33:38 PM
276	Hurray hurray for the 9th of May. I like green	Shilling	05/09/2018 9:37:47 PM
275	MAY 9TH, 2018 Endonovo Therapeutics Signs	CyberC	05/09/2018 4:40:45 PM
274	Mr. Mann is up to: Common Stock 04/30/2018	CyberC	05/07/2018 5:18:52 PM
273	Good article. Investors must	Shilling	04/15/2018 1:19:26 AM
272	Good article. Must read	Shilling	04/15/2018 1:18:19 AM
271	Healthcare Companies Capitalizing on a Resurgent	CyberC	04/10/2018 12:34:23 PM
270	Are you talking about it will cost us shares by	Shilling	03/25/2018 1:39:43 AM
269	Thank you Seeheck for your	CyberC	03/08/2018 5:42:01 PM
268	From what Ive heard and been able to gather, (2)	Seeheck	03/06/2018 11:18:16 AM
267	Mann is still at it. Table I - Non-Derivative	CyberC	03/01/2018 11:26:55 PM
265	I'm curious too, all the reports are better than	CyberC	02/28/2018 12:28:10 AM
264	Seaheck - are u still on here? Any thoughts as to	NewbieJ	02/21/2018 8:00:26 AM
263	Endonovo Therapeutics, Inc. (OTCQB: ENDV) Market	CyberC	02/20/2018 4:37:33 PM
262	Mann up to 24,823,189 shares	CyberC	02/17/2018 10:44:08 PM
261	Every study that is released has been better than	CyberC	02/17/2018 10:43:02 PM

Newer

Older

Recent Articles

• LeMaitre Vascular Engages Investors with Upcoming Conferences
• Hims & Hers Health Stock Surge Fueled by FDA Nomination Buzz
• Clearway Energy Expands Portfolio with New Wind Project Acquisition
• Marqeta, Inc. Investors Urged to Explore Legal Options
• Exciting Insights on Palazestrant and Ribociclib Presentation
• OnKure Therapeutics Schedules Investor Call for Key Updates
• Exciting Breakthroughs in Breast Cancer Treatment by Arvinas
• Steel Keg Association Promotes Reusable Kegs Amid Leadership Change
• Investors Urged to Join Humacyte, Inc. Class Action Lawsuit
• Minnesota's Cannabis Lottery Delayed Amid Legal Challenges
• Kohl's Welcomes Ashley Buchanan as CEO to Foster Growth
• State Street's $2.25 Billion Debt: Fostering Inclusion in Finance
• Faraday Future Reinvents Its Stock Symbol to Emphasize AI
• Golub Capital BDC Introduces Major $150 Million Note Offering
• HPH Sees Board Changes Amid Strategic Transformation
• Eastman Kodak's Strategic Pension Plan Move and Market Impact
• HPH Announces Leadership Transition and Future Focus
• SpaceX to Launch NASA's Dragonfly Mission to Titan
• Clairvest's New Partnership with Redstone Food Group
• Automotive Properties REIT Acquires Key Montreal Rental Properties
• Tim Draper Enthusiastically Predicts Bitcoin's Striking Rise
• Hennessy Advisors' ESG ETF to Transfer Listings to Nasdaq
• Agora, Inc. Sees Strategic Shifts Amid Financial Adjustments
• Hesai Group Announces Impressive Q3 2024 Financial Growth
• Creative Global Technology Holdings' Upcoming IPO Details
• Central Garden & Pet Reports Q4 Earnings: Key Insights Revealed
• Analyzing Woodward's Q4 Earnings and Future Outlook
• Blue Bird's Financial Performance in the Latest Earnings Report
• Central Garden & Pet Reports Strong Q4 Earnings Performance
• Central Garden & Pet's Strong Q4 Earnings Highlights
• Enanta Pharma's Earnings Report Highlights for Investors in 2024
• Woodward Reports Strong Q4 Earnings, Offers Positive Guidance Ahead
• Blue Bird's Fourth Quarter Earnings: Key Insights and Analysis
• Leslie's Performance in Q4: Key Insights and Future Prospects
• Exploring Central Garden & Pet's Recent Earnings Performance
• Insights into Enanta Pharma's Q4 Earnings Performance
• Blue Bird's Q4 Earnings Report Reveals Key Insights
• NHTSA Stands Firm on New Emergency Braking Rule for Vehicles
• Columbia Financial Appoints Matthew Smith as New COO
• Impact of Treasury Picks on Markets and Emerging Economies
• Market Reactions: Insights on Zoom, Agilent, HanesBrands, Kohl's
• Zoom Communications Enhances Forecast Following Strong Q3 Results
• Leadership Transition at Kohl's: Kingsbury's Departure Announced
• Tempest Therapeutics to Showcase Innovations at Key Conference
• Travere Therapeutics Announces Key Upcoming Investor Conferences
• Tesla Stock Faces Market Challenges Amid California Proposals
• Chegg Inc. Experience Stock Surge Following Debt Repurchase Deal
• Zoom Communications Turns a Profit with Impressive Q3 Earnings
• First Capital, Inc. Declares New Quarterly Dividend for Investors
• Columbia Financial Welcomes New COO Matthew Smith Amid Changes